{"id":35844,"date":"2025-10-06T10:32:42","date_gmt":"2025-10-06T08:32:42","guid":{"rendered":"https:\/\/ggba.swiss\/?p=35844"},"modified":"2025-10-06T10:32:44","modified_gmt":"2025-10-06T08:32:44","slug":"hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/","title":{"rendered":"HemostOD raises CHF 4.3 million to scale production of universal blood platelets"},"content":{"rendered":"\n<p>Founded in Lausanne, <a href=\"https:\/\/www.hemostod.com\/\">HemostOD<\/a> is pioneering ex vivo platelet production using immortalized hematopoietic stem cells and a proprietary bioreactor platform. The company aims to address the recurring global shortages of platelets that compromise treatments for patients with cancer, trauma, or bleeding disorders. By eliminating reliance on donors and improving quality and safety, HemostOD\u2019s universal platelet technology has the potential to transform transfusion medicine.<\/p>\n\n\n\n<p>The CHF 4.3 million Seed-extension round was co-led by <a href=\"https:\/\/www.polytechventures.ch\/\">Polytech Ventures<\/a> and Orenok Holdings, with participation from the <a href=\"https:\/\/lichtsteinerfoundation.org\/\">Lichtsteiner Foundation<\/a> and private investors. The new funding brings HemostOD\u2019s total capital raised to CHF 6 million since its initial seed round in 2021.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">From laboratory breakthrough to industrial readiness<\/h4>\n\n\n\n<p>The proceeds will be used to launch a commercial-scale pilot production line and prepare for a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA). These two milestones represent crucial steps toward regulatory engagement and clinical validation.<\/p>\n\n\n\n<p>\u201cRecurring shortages for platelets compromise medical care from cancer to trauma\u2014this is a life-threatening issue that we are confident we can address,\u201d said Faouzi Khechana, CEO of HemostOD. \u201cThis financing marks an important inflection point as we move from proof-of-concept to industrialization, bringing us closer to a safe and reliable solution for patients worldwide.\u201d<\/p>\n\n\n\n<p>Investors emphasized both the scientific and societal potential of HemostOD\u2019s work. \u201cThe company\u2019s innovative approach addresses a major unmet medical need, and we are confident in its ability to scale,\u201d said Guillaume Dubray, CEO of Polytech Ventures. Laurent Massuyeau, President of Orenok Holdings, added that HemostOD\u2019s technology \u201cpaves the way for multiple breakthrough applications, from hematology to advanced therapeutic delivery systems.\u201d<\/p>\n\n\n\n<p>With this funding, HemostOD strengthens its position as one of Western Switzerland\u2019s most promising biotech ventures, advancing a universal and sustainable solution to platelet supply challenges worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>HemostOD has raised CHF 4.3 million in a Seed-extension round to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets. The new funding marks a key milestone for the EPFL spin-off as it transitions from proof-of-concept to large-scale manufacturing.<\/p>\n","protected":false},"author":6,"featured_media":35845,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,894,902,886],"class_list":["post-35844","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-financing","tag-personalized-medicine","tag-rd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HemostOD raises CHF 4.3 million for its universal blood platelets<\/title>\n<meta name=\"description\" content=\"HemostOD has raised CHF 4.3 million to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HemostOD raises CHF 4.3 million for its universal blood platelets\" \/>\n<meta property=\"og:description\" content=\"HemostOD has raised CHF 4.3 million to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T08:32:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-06T08:32:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"HemostOD raises CHF 4.3 million to scale production of universal blood platelets\",\"datePublished\":\"2025-10-06T08:32:42+00:00\",\"dateModified\":\"2025-10-06T08:32:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\"},\"wordCount\":310,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png\",\"keywords\":[\"Biotech\",\"Financing\",\"Personalized Medicine\",\"R&amp;D\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\",\"url\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\",\"name\":\"HemostOD raises CHF 4.3 million for its universal blood platelets\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png\",\"datePublished\":\"2025-10-06T08:32:42+00:00\",\"dateModified\":\"2025-10-06T08:32:44+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"HemostOD has raised CHF 4.3 million to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"HemostOD develops donor-free human blood platelets using proprietary bioreactor technology. | \u00a9 HemostOD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HemostOD raises CHF 4.3 million to scale production of universal blood platelets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HemostOD raises CHF 4.3 million for its universal blood platelets","description":"HemostOD has raised CHF 4.3 million to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/","og_locale":"en_US","og_type":"article","og_title":"HemostOD raises CHF 4.3 million for its universal blood platelets","og_description":"HemostOD has raised CHF 4.3 million to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets.","og_url":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-06T08:32:42+00:00","article_modified_time":"2025-10-06T08:32:44+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"HemostOD raises CHF 4.3 million to scale production of universal blood platelets","datePublished":"2025-10-06T08:32:42+00:00","dateModified":"2025-10-06T08:32:44+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/"},"wordCount":310,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png","keywords":["Biotech","Financing","Personalized Medicine","R&amp;D"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/","url":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/","name":"HemostOD raises CHF 4.3 million for its universal blood platelets","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png","datePublished":"2025-10-06T08:32:42+00:00","dateModified":"2025-10-06T08:32:44+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"HemostOD has raised CHF 4.3 million to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/HemostOD-1180x811-1.png","width":1180,"height":811,"caption":"HemostOD develops donor-free human blood platelets using proprietary bioreactor technology. | \u00a9 HemostOD"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/hemostod-raises-chf-4-3-million-to-scale-production-of-universal-blood-platelets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"HemostOD raises CHF 4.3 million to scale production of universal blood platelets"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=35844"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35844\/revisions"}],"predecessor-version":[{"id":35848,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35844\/revisions\/35848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/35845"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=35844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=35844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=35844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}